Acknowledging concerns regarding some proposals in the January
2014 proposed rule for the Medicare Advantage and Part D Programs,
the Centers for Medicare & Medicaid Services states it does
"not plan to finalize" certain proposals at this
time.
In a rare, if not unprecedented step, Marilyn Tavenner,
Administrator for the Centers for Medicare & Medicaid Services
(CMS) announced in a March 10, 2014, letter to Rep. Henry Waxman
(D-Calif.) that the agency "do[es] not plan to finalize"
several controversial proposals aimed at changing the Medicare
Prescription Drug (Part D) Program that were part of CMS'
January 10, 2014, Medicare Advantage (MA) and Part D proposed
regulation (the Proposed Rule). The letter was issued on the
first business day after the close of the Proposed Rule's
comment period, during which the agency received more than 7,000
comments. It also comes amidst intense and increasing pressure from
various members of Congress and industry stakeholders.